Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy.
D000293:Adolescent; D001215:Asparaginase / Q000009:adverse effects*; D002648:Child; D003920:Diabetes Mellitus / Q000139:chemically induced; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007938:Leukemia / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D010179:Pancreas / Q000187:drug effects; D010195:Pancreatitis / Q000139:chemically induced*; D012737:Sex Factors; D013997:Time Factors
D001215:Asparaginase